No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir microbiologystudy


Antimicrobial Agents and Chemotherapy, Volume 68, Issue 7, July 2024.

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top